Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypersensitivity hepatitis due to pyrazinamide

X Corbella1, M Vadillo, C Cabellos

  • 1Department of Infectious Diseases, Hospital de Bellvitge, University of Barcelona, Spain.

Scandinavian Journal of Infectious Diseases
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Pyrazinamide is generally safe, but this case suggests it can cause liver damage through an allergic reaction. Further investigation into hypersensitivity is warranted for this tuberculosis drug.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Recommendations to develop Care Models for patients with Heart Failure (MAIC Project) from macromanagement].

Journal of healthcare quality research·2021
Same author

Inhibition of SARS-CoV-2 replication using calcineurin inhibitors: are concentrations required clinically achievable?

Journal of internal medicine·2021
Same author

Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol.

Contemporary clinical trials communications·2021
Same author

The Hospital of the Future in 10 points.

Revista clinica espanola·2020
Same author

Gender differences in hereditary hemorrhagic telangiectasia severity.

Orphanet journal of rare diseases·2020
Same author

First hospital admission due to heart failure: In-hospital mortality and patient profile.

Revista clinica espanola·2018
Same journal

Fas-Ligand Mediated Apoptosis in Severe Sepsis and Shock.

Scandinavian journal of infectious diseases·2017
Same journal

Lipopolysaccharide-inducible Gene Expression Profile in Human Monocytes.

Scandinavian journal of infectious diseases·2017
Same journal

Fatal varicella pneumonia.

Scandinavian journal of infectious diseases·2015
Same journal

Wissler's Syndrome Associated with Parainfluenza 2 Infection.

Scandinavian journal of infectious diseases·2015
Same journal

Contamination of smears with "sergentella spiroides".

Scandinavian journal of infectious diseases·2015
Same journal

Recrudescent typhus: fluctuations in titers of complement-fixing and microagglutinating antibodies to rickettsia prowazeki in persons with a history of epidemic typhus.

Scandinavian journal of infectious diseases·2015
See all related articles

Area of Science:

  • Hepatology
  • Pharmacology
  • Immunology

Background:

  • Pyrazinamide is a crucial first-line antituberculosis drug.
  • Hepatotoxicity is a known, though uncommon, side effect of pyrazinamide therapy.
  • The mechanism of pyrazinamide-induced liver injury is often attributed to direct dose-related toxicity.